Web Analysis for Ocrelizumab - ocrelizumab.us
Learn about OCREVUS® (ocrelizumab), a prescription medicine used to treat adults with relapsing or primary progressive multiple sclerosis. See full safety for more information.
ocrelizumab.us is 8 years 9 months old. It is a domain having us extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently by users, ocrelizumab.us is SAFE to browse.
PageSpeed Score
Siteadvisor Rating
Traffic Report
Daily Unique Visitors: | Not Applicable |
Daily Pageviews: | Not Applicable |
Estimated Valuation
Income Per Day: | $ 0.15 |
Estimated Worth: | $ 8.95 |
Search Engine Indexes
Google Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
Google Backlinks: | Not Applicable |
Bing Backlinks: | Not Applicable |
Safety Information
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: | Not Applicable |
WOT Child Safety: | Not Applicable |
Website Ranks & Scores
Alexa Rank: | Not Applicable |
Domain Authority: | Not Applicable |
Web Server Information
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
H1 Headings: | Not Applicable | H2 Headings: | 10 |
H3 Headings: | Not Applicable | H4 Headings: | 6 |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | Not Applicable | Total Images: | 9 |
Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Websites Hosted on Same IP (i.e. 72.34.128.116)
Genentech: 404 Page Not Found
Breakthrough science. One moment, one day, one person at a time.
Genentech
Breakthrough science. One moment, one day, one person at a time.
Cancer Education and Information | BioOncology
Explore new research in cancer and learn how Genentech is dedicated to investigating diverse biological pathways and disease targets.
Erivedge® (vismodegib) | Advanced Basal Cell Carcinoma Treatment Optio
Learn about Erivedge® (vismodegib) as a basal cell carcinoma therapy option for both metastatic and locally advanced carcinomas. See full safety and Boxed Warning for more information.
About Idiopathic Pulmonary Fibrosis (IPF) Disease | Face IPF
Learn about idiopathic pulmonary fibrosis (IPF) and gain access to IPF resources & support–like tips to manage IPF symptoms–for patients and caregivers.
HTTP Header Analysis
Accept-Ranges: bytes
Content-Encoding: gzip
Content-Type: text/html; charset=UTF-8
Date: Mon, 06 Apr 2020 09:40:55 GMT
Server: Apache
Vary: Accept-Encoding
Content-Length: 17579
Connection: Close
Domain Information
Domain Nameserver Information
Host | IP Address | Country | |
---|---|---|---|
dnadns3e.gene.com | 72.34.133.50 | United States of America | |
dnadns4e.gene.com | 72.34.128.50 | United States of America |
DNS Record Analysis
Host | Type | TTL | Extra |
---|---|---|---|
ocrelizumab.us | A | 3600 |
IP: 72.34.128.116 |
ocrelizumab.us | NS | 86400 |
Target: dnadns4e.gene.com |
ocrelizumab.us | NS | 86400 |
Target: dnadns2e.gene.com |
ocrelizumab.us | NS | 86400 |
Target: dnadns3e.gene.com |
ocrelizumab.us | SOA | 3600 |
MNAME: bc-dns-ext-mstr.gene.com RNAME: postmaster.no.email.please Serial: 559733278 Refresh: 3600 Retry: 600 Expire: 2592000 Minimum TTL: 3600 |
Full WHOIS Lookup
Registry Domain ID: D50488746-US
Registrar WHOIS Server: whois.safenames.net
Registrar URL: whois.safenames.net
Updated Date: 2019-08-14T23:45:14Z
Creation Date: 2015-08-12T15:24:58Z
Registry Expiry Date: 2020-08-11T23:59:59Z
Registrar: Safenames Ltd
Registrar IANA ID: 447
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Registry Registrant ID: C50488743-US
Registrant Name: Domain Admin
Registrant Organization: Genentech, Inc
Registrant Street: 1 DNA Way
Registrant Street:
Registrant Street:
Registrant City: South San Francisco
Registrant State/Province: CA
Registrant Postal Code: 94080-4918
Registrant Country: US
Registrant Phone: +1.6502251000
Registrant Phone Ext:
Registrant Fax: +1.6502251000
Registrant Fax Ext:
Registrant Email: domain-management-d@gene.com
Registrant Application Purpose: P1
Registrant Nexus Category: C21
Registry Admin ID: C50488740-US
Admin Name: Domain Admin
Admin Organization: Genentech, Inc
Admin Street: 1 DNA Way
Admin Street:
Admin Street:
Admin City: South San Francisco
Admin State/Province: CA
Admin Postal Code: 94080-4918
Admin Country: US
Admin Phone: +1.6502251000
Admin Phone Ext:
Admin Fax: +1.6502251000
Admin Fax Ext:
Admin Email: domain-management-d@gene.com
Admin Application Purpose: P1
Admin Nexus Category: C21
Registry Tech ID: C50488741-US
Tech Name: Domain Admin
Tech Organization: Genentech, Inc
Tech Street: 1 DNA Way
Tech Street:
Tech Street:
Tech City: South San Francisco
Tech State/Province: CA
Tech Postal Code: 94080-4918
Tech Country: US
Tech Phone: +1.6502251000
Tech Phone Ext:
Tech Fax: +1.6502251000
Tech Fax Ext:
Tech Email: domain-management-d@gene.com
Tech Application Purpose: P1
Tech Nexus Category: C21
Name Server: dnadns3e.gene.com
Name Server: dnadns4e.gene.com
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of WHOIS database: 2020-04-06T09:41:04Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NeuStar, Inc., the Registry Administrator for .US, has collected this information for the WHOIS database through a .US-Accredited Registrar. This information is provided to you for informational purposes only and is designed to assist persons in determining contents of a domain name registration record in the NeuStar registry database. NeuStar makes this information available to you "as is" and does not guarantee its accuracy. By submitting a WHOIS query, you agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data: (1) to allow, enable, or otherwise support the transmission of mass unsolicited, commercial advertising or solicitations via direct mail, electronic mail, or by telephone; (2) in contravention of any applicable data and privacy protection laws; or (3) to enable high volume, automated, electronic processes that apply to the registry (or its systems). Compilation, repackaging, dissemination, or other use of the WHOIS database in its entirety, or of a substantial portion thereof, is not allowed without NeuStar's prior written permission. NeuStar reserves the right to modify or change these conditions at any time without prior or subsequent notification of any kind. By executing this query, in any manner whatsoever, you agree to abide by these terms. NOTE: FAILURE TO LOCATE A RECORD IN THE WHOIS DATABASE IS NOT INDICATIVE OF THE AVAILABILITY OF A DOMAIN NAME. All domain names are subject to certain additional domain name registration rules. For details, please visit our site at www.whois.us.